Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer.
about
Highlight: BRCA1 and BRCA2 proteins in breast cancerBRCAness: finding the Achilles heel in ovarian cancerA delayed chemically induced tumorigenesis in Brca2 mutant mice.(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.Transcriptional profiling and dynamical regulation analysis identify potential kernel target genes of SCYL1-BP1 in HEK293T cells.Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survivalThe therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancersPrediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patientsPharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy.Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": a review.Analysis of resistance-associated gene expression in docetaxel-resistant prostate cancer cells.The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients.Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers.
P2860
Q24307401-D64A734C-B66A-4A45-9AA7-9DB58C51190AQ24630872-82B85656-1CB5-4179-987B-420045151BD8Q33198599-8239D9F0-170E-4E4E-92D9-4597DE051DE9Q33892907-AA52214A-0D8A-4751-A60A-56BE8D3708E2Q33962070-7F56C3EE-0AB1-4E45-9F7D-E1C644804CB2Q34123323-1569EB37-EE74-42C1-A442-D7B72DE3E3CBQ34263334-059F37BA-2DBF-4205-BC86-C2799887AB40Q34449010-7F7537CE-78CC-4B77-BE6C-1C14201DD3ACQ35014762-1C5870C5-71D4-44F3-B105-1252EB2B89BDQ36117673-2AF2F548-2300-471A-ABCE-C93877358392Q36273435-7BE99079-0809-4050-8ED6-75B47D9EC8DDQ37128739-87350989-CC6F-4192-BC4E-1308B0E7D63EQ41611182-1E343F33-C28C-4189-B871-DDDB7AF2CF53Q45899064-9007E09A-2656-409D-9350-161C676F1901Q48163701-102EBDCE-402F-4C5F-8EF7-A9ECADBB805E
P2860
Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Decreased expression of BRCA2 ...... to docetaxel in breast cancer.
@en
Decreased expression of BRCA2 ...... to docetaxel in breast cancer.
@nl
type
label
Decreased expression of BRCA2 ...... to docetaxel in breast cancer.
@en
Decreased expression of BRCA2 ...... to docetaxel in breast cancer.
@nl
prefLabel
Decreased expression of BRCA2 ...... to docetaxel in breast cancer.
@en
Decreased expression of BRCA2 ...... to docetaxel in breast cancer.
@nl
P2093
P2860
P1476
Decreased expression of BRCA2 ...... to docetaxel in breast cancer.
@en
P2093
P2860
P304
P356
10.1002/1097-0215(20010720)95:4<255::AID-IJC1043>3.0.CO;2-O
P577
2001-07-01T00:00:00Z